SureNano Science Initiates FDA Stage GLP Toxicology and Pharmacology Studies for GLP GEP-44 and Enters Discussions to Acquire Ibogaine Formulation IP Portfolio

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. CBRS
2. KBH
3. FDX
4. HONA
5. HTZ
6. HON
7. TTWO
8. HELP
9. GDYN
10. NKE

Go back to SureNano Science Initiates FDA Stage GLP Toxicology and Pharmacology Studies for GLP GEP-44 and Enters Discussions to Acquire Ibogaine Formulation IP Portfolio
(AMEX: SURNF) Delayed: 0.11 --0 (-0%)
Previous Close $0.11    52 Week High $ 
Open $0.11    52 Week Low $ 
Day High $0.11    P/E N/A 
Day Low $0.11    EPS $ 
Volume 20,252